SPECT Imaging of Acute Disc Herniation by Targeting Integrin α5β1 in Rat Models.
- Published in:
- Frontiers in Neurology, 2022, v. 13, p. 1, doi. 10.3389/fneur.2022.782967
- By:
- Publication type:
- Article
Works by Gao, Hannan
Results: 9
1
2
Palmitic Acid-Conjugated Radiopharmaceutical for Integrin α v β 3 -Targeted Radionuclide Therapy.
- Published in:
- Pharmaceutics, 2022, v. 14, n. 7, p. N.PAG, doi. 10.3390/pharmaceutics14071327
- By:
- Publication type:
- Article
3
A <sup>64</sup>Cu‐porphyrin‐based dual‐modal molecular probe with integrin α<sub>v</sub>β<sub>3</sub> targeting function for tumour imaging.
- Published in:
- Journal of Labelled Compounds & Radiopharmaceuticals, 2020, v. 63, n. 5, p. 212, doi. 10.1002/jlcr.3833
- By:
- Publication type:
- Article
4
Nuclear imaging of PD-L1 expression promotes the synergistic antitumor efficacy of targeted radionuclide therapy and immune checkpoint blockade.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2025, v. 52, n. 3, p. 955, doi. 10.1007/s00259-024-06962-w
- By:
- Publication type:
- Article
5
Preclinical evaluation of [<sup>99m</sup>Tc]Tc-labeled anti-EpCAM nanobody for EpCAM receptor expression imaging by immuno-SPECT/CT.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 6, p. 1810, doi. 10.1007/s00259-021-05670-z
- By:
- Publication type:
- Article
6
[<sup>99M</sup>Tc]Tc-MY6349 Probe for Trop2-Targeted SPECT Imaging: From Preclinical to Pilot Clinical Study.
- Published in:
- Journal of Nuclear Medicine, 2025, v. 66, n. 4, p. 543, doi. 10.2967/jnumed.124.268564
- By:
- Publication type:
- Article
7
Molecular imaging of HER2 expression in breast cancer patients using a novel peptide-based tracer <sup>99m</sup>Tc-HP-Ark2: a pilot study.
- Published in:
- Journal of Translational Medicine, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12967-022-03865-y
- By:
- Publication type:
- Article
8
Comparison of [<sup>99m</sup>Tc]Tc-FAPI SPECT/CT and [<sup>18</sup>F]FDG PET/CT as predictive biomarkers for immunotherapy response in gastrointestinal cancer.
- Published in:
- Nature Communications, 2025, v. 16, n. 1, p. 1, doi. 10.1038/s41598-025-01577-z
- By:
- Publication type:
- Article
9
A Dual pH-Responsive DOX-Encapsulated Liposome Combined with Glucose Administration Enhanced Therapeutic Efficacy of Chemotherapy for Cancer.
- Published in:
- International Journal of Nanomedicine, 2021, v. 16, p. 3185, doi. 10.2147/IJN.S303874
- By:
- Publication type:
- Article